Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - St. Jude Medical, Inc. (NYSE:STJ)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
July 30Price hit new 52-week high ($72.06)
Location
One Lillehei Plaza
St. Paul, MN 55117
Phone: (651) 483-2000
Fax: (651) 482-8318
Employees (last reported count): 4,951
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 16%
·Over the last 6 months:
 · one insider buy; 3,000  shares
 · 7 insider sells; 279.0K shares
  (2.0% of insider shares)
·Institutional: 76% (91% of float)
(697 institutions)
·Net Inst. Buying: 2.53M shares (+3.69%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
St. Jude Medical, Inc., together with its subsidiaries, is engaged in the development, manufacturing and distribution of medical technology products for the cardiac rhythm management, cardiology and vascular access, and cardiac surgery markets. St. Jude has two segments, Cardiac Rhythm Management (CRM) and Cardiac Surgery (CS, formerly known as Heart Valve Disease Management). The CRM segment, which includes the results from the Company's Cardiac Rhythm Management Division and Daig Division, develops, manufactures and distributes bradycardia pulse generator and tachycardia implantable cardioverter defibrillator (ICD) systems, electrophysiology and interventional cardiology catheters and vascular closure devices. The CS segment develops, manufactures and distributes mechanical and tissue heart valves and valve repair products, and suture-free devices to facilitate coronary artery bypass graft anastomoses.
More from Market Guide: Expanded Business Description

Financial Summary
St. Jude Medical designs, manufactures, and markets medical devices primarily for cardiac care. Products include heart valve disease management devices, cardiac rhythm management and interventional cardiology devices. For the six months ended 6/30/01, revenues rose 11% to $662.1 million. Net income rose 82% to $90.9 million. Revenues reflect higher bradycardia and Angio-Seal products sales. Earnings also reflect the absence of a $26.1 million special charge.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Ronald Matricaria, 58
Chairman
$1.1M$281K
Terry Shepherd, 48
CEO, Director
1.1M--  
Daniel Starks, 46
Pres, COO, Director
707K--  
John Heinmiller, 46
VP- Fin., CFO
471K--  
Kevin O'Malley, 49
VP, Gen. Counsel
446K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:STJAs of 31-Aug-2001
Price and Volume
52-Week Low
on 1-Sep-2000
$39.625
Recent Price$68.80 
52-Week High
on 30-July-2001
$72.06 
Beta0.56 
Daily Volume (3-month avg)627.2K
Daily Volume (10-day avg)432.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+67.9%
52-Week Change
relative to S&P500
+125.3%
Share-Related Items
Market Capitalization$5.95B
Shares Outstanding86.5M
Float72.7M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 17-Nov-1995
Per-Share Data
Book Value (mrq)$11.88 
Earnings (ttm)$1.93 
Earnings (mrq)$0.49 
Sales (ttm)$14.16 
Cash (mrq)$1.43 
Valuation Ratios
Price/Book (mrq)5.79 
Price/Earnings (ttm)35.59 
Price/Sales (ttm)4.86 
Income Statements
Sales (ttm)$1.24B
EBITDA (ttm)$334.0M
Income available to common (ttm)$170.0M
Profitability
Profit Margin (ttm)13.7%
Operating Margin (ttm)19.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)11.04%
Return on Equity (ttm)18.08%
Financial Strength
Current Ratio (mrq)2.38 
Debt/Equity (mrq)0.22 
Total Cash (mrq)$123.3M
Short Interest
As of 8-Aug-2001
Shares Short808.0K
Percent of Float1.1%
Shares Short
(Prior Month)
1.16M
Short Ratio0.84 
Daily Volume957.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.